Display options
Share it on

Met Ions Biol Med. 2008 Jan 01;10:458-462.

Cytotoxic Effect of Arsenic Trioxide in Adenocarcinoma Colorectal Cancer (HT-29) Cells.

Metal ions in biology and medicine : proceedings of the ... International Symposium on Metal Ions in Biology and Medicine held ... = Les ions metalliques en biologie et en medecine : ... Symposium international sur les ions metalliques ...

Jacqueline J Stevens, Barbara Graham-Evans, Alice M Walker, Brinda Armstead, Paul B Tchounwou

Affiliations

  1. Molecular and Cellular Biology Research Laboratory and Molecular Toxicology Research Laboratory, NIH-Center for Environmental Health, College of Science, Engineering and Technology, Jackson State University, 1400 JR Lynch Street, Box 18540, Jackson, Mississippi, USA.

PMID: 21603592 PMCID: PMC3096487

Abstract

Arsenic is a heavy metal that exhibits a high degree of toxicity to various organ systems. In humans, this compound is associated with an increase risk of skin cancer, and may cause cancers of the lung, liver, bladder, kidney, and colon. The mechanism of arsenic-related carcinogenicity remains to be elucidated. Hence, the aim of the present study was to investigate the cytotoxic effects of arsenic trioxide (As(2)O(3)) on adenocarcinoma colorectal cancer (HT-29) cells using the MTT [3-(4,5 dimethylthiazoyl-2-yl)-2,5- diphenyltetrazolium bromide] assay for cell viability. To achieve this objective, HT-29 cells were cultured and exposed to various doses (0, 2, 4, 6, 8, 10, 12, and 14 μg/ml) of arsenic trioxide for 24 h, 48 h, and 72 h respectively, and subsequently assessed for viability following a standard MTT test protocol. Experimental data indicated that arsenic trioxide is cytotoxic to colon cancer cells showing LD(50) values of 9.8, 9.4 and 9.0 μg/ml upon 24, 48 and 72 h of exposure, respectively. There was a dose-dependent response with regard to As(2)O(3) toxicity in HT-29 cells. Although there was a reduction in LD(50) value with increasing exposure time, this decrease was not statistically significant.

References

  1. Toxicol Lett. 2002 Jul 7;133(1):1-16 - PubMed
  2. Environ Health Perspect. 1994 Sep;102 Suppl 3:101-5 - PubMed
  3. Environ Health Perspect. 1999 Jul;107(7):593-7 - PubMed
  4. Environ Health Perspect. 2002 Oct;110 Suppl 5:797-9 - PubMed
  5. Mol Cell Biochem. 2007 Jul;301(1-2):123-30 - PubMed
  6. Cancer Res. 2002 Jul 15;62(14):3893-903 - PubMed
  7. Toxicol Pathol. 2003 Nov-Dec;31(6):575-88 - PubMed
  8. J Cell Biochem. 2004 Sep 1;93(1):173-87 - PubMed
  9. Altern Med Rev. 2003 May;8(2):106-28 - PubMed
  10. J Immunol Methods. 1983 Dec 16;65(1-2):55-63 - PubMed
  11. Met Ions Biol Med. 2006;9:298-303 - PubMed
  12. CA Cancer J Clin. 2001 Jul-Aug;51(4):254-62 - PubMed
  13. Environ Health Perspect. 2006 Nov;114(11):1790-6 - PubMed
  14. Clin Cancer Res. 2000 Dec;6(12):4957-64 - PubMed
  15. Environ Health Perspect. 2007 Jul;115(7):A339-40; author reply A340-1 - PubMed
  16. Blood. 1996 Aug 1;88(3):1052-61 - PubMed

Publication Types

Grant support